James J Herrmann

Title: Innovations of James J Herrmann

Introduction

James J Herrmann is a notable inventor based in Elmhurst, IL (US). He has made significant contributions to the field of immunology, particularly in the development of therapies for inflammatory and autoimmune diseases. With a total of 3 patents to his name, Herrmann's work is recognized for its potential impact on medical treatments.

Latest Patents

Herrmann's latest patents include innovative methods and compositions for treating inflammatory and autoimmune diseases. One of his key inventions is focused on the use of anti-αβ TCR antibodies and antibody fragments. These antibodies are designed to selectively inhibit T-cell responses, which can be crucial in managing conditions such as tissue rejection in transplants. The methods outlined in his patents also emphasize the therapeutic use of ex vivo expanded regulatory T-cells, showcasing a comprehensive approach to treatment.

Career Highlights

James J Herrmann is currently associated with Tolera Therapeutics, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving patient outcomes through innovative therapeutic strategies.

Collaborations

Throughout his career, Herrmann has collaborated with esteemed colleagues, including Daniel R Getts and John J Puisis. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical solutions.

Conclusion

James J Herrmann's contributions to the field of immunology through his patents and collaborative efforts highlight his dedication to advancing medical science. His innovative approaches have the potential to significantly improve treatments for various diseases.